MA vs ORMP
Mastercard Inc (MA) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MA revenue for 2025-12-31 was $32.79B. Net income was $14.97B. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MA currently screens at market cap $515.12B and trailing P/E 38.4. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MA and ORMP stock pages for the full models.
Not investment advice.